Harmony Biosciences
HRMY
HRMY
221 hedge funds and large institutions have $1.58B invested in Harmony Biosciences in 2023 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 62 increasing their positions, 77 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
3% less capital invested
Capital invested by funds: $1.62B → $1.58B (-$43M)
19% less repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 77
Holders
221
Holding in Top 10
6
Calls
$5.6M
Puts
$1.78M
Top Buyers
| 1 | +$45.8M | |
| 2 | +$39.6M | |
| 3 | +$24.2M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$16.2M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$7.35M |
Top Sellers
| 1 | -$42.6M | |
| 2 | -$32.6M | |
| 3 | -$19.5M | |
| 4 |
ACM
Ashford Capital Management
Wilmington,
Delaware
|
-$14.2M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$12.2M |